Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Visnadine [INN:BAN]
RN: 477-32-7
UNII: 0RL4V0K263
InChIKey: GVBNSPFBYXGREE-CXWAGAITSA-N

Classification Codes

  • Drug / Therapeutic Agent
  • Natural Product

Molecular Formula

  • C21-H24-O7

Molecular Weight

  • 388.4136
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Visnadin
  • Visnadine [INN:BAN]

Synonyms

  • (alpha-Methylbutyryloxy)-3'-acetoxy-4'-dihydro-3',4'-seselin
  • (alpha-Methylbutyryloxy)-3'-acetoxy-4'-dihydro-3',4'-seselin [German]
  • 3-(alpha-Methylbutyryloxy)-4-acetoxy-3,4-dihydroseseline
  • 5-19-06-00272 (Beilstein Handbook Reference)
  • BRN 0055264
  • Cardine
  • Carduben
  • Carduben-S
  • EINECS 207-515-1
  • Selva
  • UNII-0RL4V0K263
  • Visnadin
  • Visnadina
  • Visnadina [DCIT]
  • Visnadine
  • Visnadinum
  • Visnadinum [INN-Latin]

Systematic Names

  • 3,4,5-Trihydroxy-2,2-dimethyl-6-chromanacrylic acid delta-lactone 4-acetate 3-(2-methylbutyrate)
  • Butyric acid, 2-methyl-, 9-ester with 9,10-dihydro-9,10-dihydroxy-8,8-dimethyl-2H,8H-benzo(1,2-b:3,4-b')dipyran-2-one-acetate
  • Visnadine

Registry Numbers

CAS Registry Number

  • 477-32-7

FDA UNII

  • 0RL4V0K263

System Generated Number

  • 0000477327

Structure Descriptors

InChI

1S/C21H24O7/c1-6-11(2)20(24)27-19-18(25-12(3)22)16-14(28-21(19,4)5)9-7-13-8-10-15(23)26-17(13)16/h7-11,18-19H,6H2,1-5H3/t11-,18-,19-/m1/s1

InChIKey

GVBNSPFBYXGREE-CXWAGAITSA-N

Smiles

CC[C@@H](C)C(=O)O[C@@H]1[C@H](OC(=O)C)c2c(OC1(C)C)ccc3C=CC(=O)Oc23

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LDLo intravenous 20mg/kg (20mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Arzneimittel-Forschung. Drug Research. Vol. 17, Pg. 283, 1967.
dog LDLo oral 200mg/kg (200mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Arzneimittel-Forschung. Drug Research. Vol. 17, Pg. 283, 1967.
mouse LD50 intramuscular 832mg/kg (832mg/kg)   Journal of Drug Research. Vol. 7(2), Pg. 1, 1975.
mouse LD50 oral 2240mg/kg (2240mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 17, Pg. 283, 1967.
mouse LD50 subcutaneous > 370mg/kg (370mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Arzneimittel-Forschung. Drug Research. Vol. 17, Pg. 283, 1967.
rabbit LDLo intravenous 50mg/kg (50mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 17, Pg. 283, 1967.
rabbit LDLo oral > 600mg/kg (600mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 17, Pg. 283, 1967.
rat LD50 oral 1213mg/kg (1213mg/kg)   Journal of Drug Research. Vol. 7(2), Pg. 1, 1975.